Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C28H38O6 |
Molecular Weight | 470.5977 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@H]5O[C@H](O[C@@]25C(=O)CO)C6CCCCC6
InChI
InChIKey=OXPLANUPKBHPMS-ZXBNPROVSA-N
InChI=1S/C28H38O6/c1-26-11-10-18(30)12-17(26)8-9-19-20-13-23-28(22(32)15-29,27(20,2)14-21(31)24(19)26)34-25(33-23)16-6-4-3-5-7-16/h10-12,16,19-21,23-25,29,31H,3-9,13-15H2,1-2H3/t19-,20-,21-,23+,24+,25+,26-,27-,28+/m0/s1
Molecular Formula | C28H38O6 |
Molecular Weight | 470.5977 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:28:49 GMT 2025
by
admin
on
Mon Mar 31 18:28:49 GMT 2025
|
Record UNII |
8DL7FH77SF
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
8DL7FH77SF
Created by
admin on Mon Mar 31 18:28:49 GMT 2025 , Edited by admin on Mon Mar 31 18:28:49 GMT 2025
|
PRIMARY | |||
|
161115-59-9
Created by
admin on Mon Mar 31 18:28:49 GMT 2025 , Edited by admin on Mon Mar 31 18:28:49 GMT 2025
|
PRIMARY | |||
|
DTXSID801043142
Created by
admin on Mon Mar 31 18:28:49 GMT 2025 , Edited by admin on Mon Mar 31 18:28:49 GMT 2025
|
PRIMARY | |||
|
6918281
Created by
admin on Mon Mar 31 18:28:49 GMT 2025 , Edited by admin on Mon Mar 31 18:28:49 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BINDER->LIGAND |
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
Des-ciclesonide has anti-inflammatory activity with affinity for the glucocorticoid receptor that is 120 times higher than the parent compound.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
ORAL BIOAVAILABILITY | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
INTRAVENOUS ADMINISTRATION |
|
||